These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 700357)

  • 41. Suppression of lysergic acid diethylamide (LSD) effects in pregnant rats.
    Bergen JR
    Res Commun Chem Pathol Pharmacol; 1972 Mar; 3(2):313-9. PubMed ID: 4679854
    [No Abstract]   [Full Text] [Related]  

  • 42. Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.
    Dolder PC; Schmid Y; Steuer AE; Kraemer T; Rentsch KM; Hammann F; Liechti ME
    Clin Pharmacokinet; 2017 Oct; 56(10):1219-1230. PubMed ID: 28197931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dissociations between the effects of hallucinogenic drugs on behavior and raphe unit activity in freely moving cats.
    Trulson ME; Heym J; Jacobs BL
    Brain Res; 1981 Jun; 215(1-2):275-93. PubMed ID: 6114779
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oral delta9-tetrahydrocannabinol toxicity in rats treated for periods up to six months.
    Rosendrantz H; Sprague RA; Fleischman RW; Braude C
    Toxicol Appl Pharmacol; 1975 May; 32(2):399-417. PubMed ID: 1171539
    [No Abstract]   [Full Text] [Related]  

  • 45. Detection of lysergic acid diethylamide, delta-9-tetrahydrocannabinol and related compounds by plasma chromatography.
    Karasek FW; Karasek DE; Kim SH
    J Chromatogr; 1975 Feb; 105(2):345-52. PubMed ID: 1158994
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Pharmacological action spectra of hallucinogens].
    Waser PG
    Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):39-57. PubMed ID: 5141141
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacological and toxicological effects of beta-3,4-methylenedioxyamphetamine isomers.
    Marquardt GM; DiStefano V; Ling LL
    Toxicol Appl Pharmacol; 1978 Sep; 45(3):675-83. PubMed ID: 725923
    [No Abstract]   [Full Text] [Related]  

  • 48. Behavioural actions of some substituted amphetamines.
    Buxton DA
    Prog Brain Res; 1972; 36():171-81. PubMed ID: 4644027
    [No Abstract]   [Full Text] [Related]  

  • 49. The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats.
    Commissaris R; Lyness WH; Cordon JJ; Moore KE; Rech RH
    Pharmacol Biochem Behav; 1980 Nov; 13(5):621-6. PubMed ID: 7443731
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tolerance and limited cross-tolerance to the effects of N, N-dimethyltryptamine (DMT) and lysergic acid diethylamide-25 (LSD) on food-rewarded bar pressing in the rat.
    Kovacic B; Domino EF
    J Pharmacol Exp Ther; 1976 Jun; 197(3):495-502. PubMed ID: 1064726
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Experimental LSD poisoning and its relation to schizophrenia. Observations on 2 borderline cases of neurosis and schizophrenia treated by repeated administration of LSD].
    MANZINI B; SARAVAL A
    Riv Sper Freniatr Med Leg Alien Ment; 1960 Sep; 84():589-618. PubMed ID: 13766357
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of hallucinogens and psycholeptic drugs on blood pressure reflexes and behavioral reactions in nonanesthetized cats.
    Balint GA
    Isr J Med Sci; 1972 Apr; 8(4):556-8. PubMed ID: 5034804
    [No Abstract]   [Full Text] [Related]  

  • 53. Lysergic acid diethylamide (LSD) and JB 318: a comparison of two hallucinogens. II. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    Arch Gen Psychiatry; 1960 Aug; 3():176-87. PubMed ID: 14415047
    [No Abstract]   [Full Text] [Related]  

  • 54. [Preparation of new semi-synthetic lysergic acid derivatives: correlation of molecular structure and antiserotonin acitivity. II].
    Borsy J; Magóné KE; Balogh T; Pik K
    Acta Pharm Hung; 1973 Sep; 43(5):207-17. PubMed ID: 4755754
    [No Abstract]   [Full Text] [Related]  

  • 55. LSD and phenethylamine hallucinogens: new structural analogy and implications for receptor geometry.
    Nichols DE; Pfister WR; Yim GK
    Life Sci; 1978 Jun; 22(24):2165-70. PubMed ID: 672453
    [No Abstract]   [Full Text] [Related]  

  • 56. Cumulative alterations in rat behavior during continuous administration of LSD or mescaline: absence of tolerance?
    Ellison G; Ring M; Ross D; Axelrood B
    Biol Psychiatry; 1980 Feb; 15(1):95-102. PubMed ID: 7357060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A pharmacologic comparison of 3,4-methylenedioxyamphetamine and LSD in the chronic spinal dog.
    Nozaki M; Vaupel DB; Martin WR
    Eur J Pharmacol; 1977 Dec; 46(4):339-49. PubMed ID: 590343
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of behavioral and endocrine effects of LSD on zebrafish.
    Grossman L; Utterback E; Stewart A; Gaikwad S; Chung KM; Suciu C; Wong K; Elegante M; Elkhayat S; Tan J; Gilder T; Wu N; Dileo J; Cachat J; Kalueff AV
    Behav Brain Res; 2010 Dec; 214(2):277-84. PubMed ID: 20561961
    [TBL] [Abstract][Full Text] [Related]  

  • 59. LSD, psychotogenic procedures, and brain neurohumors.
    Freedman DX
    Psychopharmacol Bull; 1975 Apr; 11(2):42-3. PubMed ID: 237298
    [No Abstract]   [Full Text] [Related]  

  • 60. The influence of synthetic "substance P" on tremor caused by LSD in mice.
    Stern P
    J Pharm Pharmacol; 1973 Mar; 25(3):259-61. PubMed ID: 4146329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.